Research staff spending more time on what matters so new treatments can get to patients faster
Be the next-generation solution for study data interconnectivity
We believe that trust is earned: our team is focused on ensuring that all we do is delivered to stringent industry protocols and the highest service standards.
Quality and data security are in our DNA and are what sets our people apart.
Our success is rooted in powerful collaborations, forged with world-renowned research sites and global pharma.
Internally and externally, our culture of inclusion and respect means we are always guided by insights, expertise and clearly defined needs.
Having successfully scaled 3 digital healthcare companies through positive transactions, Zach was brought in by the founders to accelerate IgniteData’s growth with sites and pharma partners. His focus will be on operationalizing the company, commercial team, and product for general availability and growth across the industry.
As a founder Dan led the work shaping IgniteData's value prop, commercial model and scale-up strategy. In the role of President, this focus will redouble as we further reinforce Archer's position as the market-leading global eSource-to-Sponsor solution.
Richard is laser-focused on our people, mission, and growth. Directing operations, project delivery and financial strategy, he will ensure that the regulatory-grade studies and customer support delivered by the IgniteData team are consistently world-class.
Having spent 30 years delivering best-in-class clinical products in the healthcare industry, Steve is passionate about product strategy and delivery. Working hand-in-glove with IgniteData’s customers, he will ensure product market fit and overall return on investment.
IgniteData is formed with the aim of helping to deliver efficiencies in modern clinical trials through the automated transfer of data between systems. The technology isn’t quite ready to create the scalable, system-agnostic tool that Dan and Richard envisage, so they park the idea and continue building IgniteData’s expertise in supporting clinical trial delivery.
Advances in the technologies used in EHR systems finally mean the time is right to start building the tool Dan and Richard envisage. A grant from Innovate UK helps build a prototype, and Archer – the Virtual Research Assistant – is born. It is designed to be the world’s first truly agnostic tool to safely automate the transfer of clinical data from EHR to EDC.
The emergence of the Covid-19 pandemic makes Archer – which allows for less in-person visits to clinical trial sites – even more relevant. The team win three further grants, in all being awarded over £1 million in government funding to develop Archer.
Archer is shortlisted in a vendor selection process run by the EHR2EDC Consortium (led by AstraZeneca, Janssen and Sanofi) and, ultimately, comes out at the top. This kick-starts a partnership with AstraZeneca to pilot the use of Archer in a hospital setting.
IgniteData announces a multimillion dollar investment and partnership with global professional services firm ZS, to turbocharge the transformation of patient data automation in clinical trials with Archer.
Through ZS’s worldwide life sciences presence, the partnership will open up the benefits of Archer to health systems and sponsors on a global scale.
University College London Hospitals NHS Foundation Trust (UCLH), IgniteData and AstraZeneca evaluate how Archer EHR-to-EDC transfer technology performs in a clinical trial setting. The live pilot shows that Archer can map 100% of Vital Signs and Labs data, and successfully transfer 100% of mapped data from those domains to the study databse.